TAIWAN LIPOSOME ROA 2018-2018 | TLC

Current and historical return on assets (ROA) values for TAIWAN LIPOSOME (TLC) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. TAIWAN LIPOSOME ROA for the three months ending September 30, 2018 was 0.00%.
TAIWAN LIPOSOME ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.227B $0.002B
Taiwan Liposome Company Ltd. is a specialty pharmaceutical company. It focuses on development and commercialization of novel nanomedicines designed to target unmet medical need in pain management, ophthalmology and oncology. The company's product pipeline consists of TLC599, TLC590, TLC399 and TLC178 which are in clinical stage. Taiwan Liposome Company Ltd. is headquartered in Taipei City, Taiwan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $40.478B 27.71
Takeda Pharmaceutical (TAK) Japan $30.669B 14.33
Grifols (GRFS) Spain $13.229B 16.03
Neurocrine Biosciences (NBIX) United States $8.034B 1772.00
Ionis Pharmaceuticals (IONS) United States $7.924B 0.00
Nektar Therapeutics (NKTR) United States $7.862B 11.27
Tilray (TLRY) United States $7.775B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.684B 11.03
Loxo Oncology (LOXO) United States $7.141B 0.00
Sage Therapeutics (SAGE) United States $6.398B 0.00
Catalent (CTLT) United States $5.119B 21.47
United Therapeutics (UTHR) United States $4.977B 8.14
FibroGen (FGEN) United States $4.316B 0.00
TESARO (TSRO) United States $4.125B 0.00
Impax Laboratories (AMRX) United States $3.729B 19.83
Taro Pharmaceutical Industries (TARO) Israel $3.641B 13.48
USANA Health Sciences (USNA) United States $2.796B 23.80
Endo (ENDP) Ireland $2.210B 3.38
Heron Therapeutics (HRTX) United States $2.090B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.020B 0.00
Aerie Pharmaceuticals (AERI) United States $1.947B 0.00
Xencor (XNCR) United States $1.940B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.817B 0.00
Zogenix (ZGNX) United States $1.784B 0.00
PTC Therapeutics (PTCT) United States $1.746B 0.00
Corcept Therapeutics (CORT) United States $1.722B 25.27
Portola Pharmaceuticals (PTLA) United States $1.701B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.592B 215.17
Theravance Biopharma (TBPH) Cayman Islands $1.485B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.447B 20.35
Arrowhead Pharmaceuticals (ARWR) United States $1.349B 0.00
TherapeuticsMD (TXMD) United States $1.247B 0.00
Esperion Therapeutics (ESPR) United States $1.179B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.126B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.012B 0.00
Tricida (TCDA) United States $0.900B 0.00
Radius Health (RDUS) United States $0.772B 0.00
ImmunoGen (IMGN) United States $0.750B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.635B 0.00
ChemoCentryx (CCXI) United States $0.626B 49.56
Siga Technologies (SIGA) United States $0.594B 0.00
Karyopharm Therapeutics (KPTI) United States $0.589B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.573B 0.00
Collegium Pharmaceutical (COLL) United States $0.533B 0.00
Flexion Therapeutics (FLXN) United States $0.517B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.483B 28.47
Forty Seven (FTSV) United States $0.472B 0.00
Odonate Therapeutics (ODT) United States $0.469B 0.00
GlycoMimetics (GLYC) United States $0.457B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.435B 0.00
ArQule (ARQL) United States $0.412B 0.00
Tyme Technologies (TYME) United States $0.385B 0.00
CASI Pharmaceuticals (CASI) United States $0.362B 0.00
Akebia Therapeutics (AKBA) United States $0.359B 0.00
Xeris Pharmaceuticals (XERS) United States $0.358B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.350B 0.00
Majesco Entertainment (PTE) United States $0.350B 0.00
Concert Pharmaceuticals (CNCE) United States $0.335B 0.00
KalVista Pharmaceuticals (KALV) United States $0.313B 0.00
OptiNose (OPTN) United States $0.300B 0.00
Lannett Co Inc (LCI) United States $0.294B 2.55
Dermira (DERM) United States $0.289B 0.00
Minerva Neurosciences (NERV) United States $0.278B 0.00
Depomed (ASRT) United States $0.269B 10.00
Catalyst Pharmaceuticals (CPRX) United States $0.268B 0.00
Tapimmune (MRKR) United States $0.267B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.265B 0.00
Translate Bio (TBIO) United States $0.260B 0.00
Mast Therapeutics (SVRA) United States $0.259B 0.00
Aclaris Therapeutics (ACRS) United States $0.255B 0.00
IMV INC (IMV) Canada $0.252B 0.00
Opexa Therapeutics (ACER) United States $0.233B 0.00
Aldeyra Therapeutics (ALDX) United States $0.229B 0.00
Dova Pharmaceuticals (DOVA) United States $0.228B 0.00
Affimed (AFMD) Germany $0.221B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.208B 0.00
Aratana Therapeutics (PETX) United States $0.201B 0.00
MEI Pharma (MEIP) United States $0.198B 0.00
Galectin Therapeutics (GALT) United States $0.195B 0.00
Aquestive Therapeutics (AQST) United States $0.193B 0.00
Rafael Holdings (RFL) United States $0.180B 0.00
Zafgen (ZFGN) United States $0.175B 0.00
Calithera Biosciences (CALA) United States $0.174B 0.00
Recro Pharma (REPH) United States $0.169B 0.00
Molecular Templates (MTEM) United States $0.164B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.164B 0.00
Ocular Therapeutix (OCUL) United States $0.163B 0.00
Jounce Therapeutics (JNCE) United States $0.155B 0.00
Nature's Sunshine Products (NATR) United States $0.154B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.154B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.147B 0.00
Redhill Biopharma (RDHL) Israel $0.146B 0.00
Ardelyx (ARDX) United States $0.144B 0.00
Adherex Technologies (FENC) United States $0.143B 0.00
Neon Therapeutics (NTGN) United States $0.143B 0.00
ElectroCore (ECOR) United States $0.141B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.136B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.135B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.132B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.132B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.123B 0.00
MediWound (MDWD) Israel $0.120B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.112B 0.00
Champions Oncology (CSBR) United States $0.110B 0.00
Cardiome Pharma (CORV) Canada $0.102B 0.00
Aptorum Group (APM) China $0.099B 0.00
ProNAi Therapeutics (SRRA) Canada $0.099B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.098B 0.00
DURECT (DRRX) United States $0.098B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.089B 0.00
Natural Alternatives (NAII) United States $0.083B 8.17
Iterum Therapeutics (ITRM) Ireland $0.083B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.075B 0.00
Nivalis Therapeutics (ALPN) United States $0.075B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.075B 0.00
Infinity Pharmaceuticals (INFI) United States $0.073B 0.00
CTI BioPharma (CTIC) United States $0.072B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.071B 0.00
KemPharm (KMPH) United States $0.070B 0.00
Avenue Therapeutics (ATXI) United States $0.069B 0.00
Immune Design (IMDZ) United States $0.067B 0.00
BioLineRx (BLRX) Israel $0.062B 0.00
Neos Therapeutics (NEOS) United States $0.062B 0.00
Otonomy (OTIC) United States $0.061B 0.00
Achaogen (AKAO) United States $0.059B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.058B 0.00
Melinta Therapeutics (MLNT) United States $0.055B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.053B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.053B 0.00
Genocea Biosciences (GNCA) United States $0.051B 0.00
Forward Pharma (FWP) Denmark $0.050B 0.00
Mannatechorporated (MTEX) United States $0.046B 0.00
ContraFect (CFRX) United States $0.044B 0.00
Lipocine (LPCN) United States $0.040B 0.00
Novan (NOVN) United States $0.040B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.038B 0.00
Capnia (SLNO) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.037B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
Heat Biologics (HTBX) United States $0.032B 0.00
PharmAthene (ALT) United States $0.027B 0.00
IsoRay (ISR) United States $0.027B 0.00
Can-Fite Biopharma (CANF) Israel $0.026B 0.00
Trillium Therapeutics (TRIL) Canada $0.026B 0.00
ESSA Pharma (EPIX) Canada $0.024B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.023B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.021B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.021B 0.00
Citius Pharmaceuticals (CTXR) United States $0.020B 0.00
Pain Therapeutics (PTIE) United States $0.020B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.020B 0.00
Xenetic Biosciences (XBIO) United States $0.019B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
HANCOCK JAFFE (HJLI) United States $0.018B 0.00
NanoViricides (NNVC) United States $0.018B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.018B 0.00
Jaguar Animal Health (JAGX) United States $0.017B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.016B 0.00
Aviragen Therapeutics (VXRT) United States $0.015B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.014B 0.00
Shineco (TYHT) China $0.013B 1.47
Skyline Medical (AIPT) United States $0.013B 0.00
Onconova Therapeutics (ONTX) United States $0.011B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Regulus Therapeutics (RGLS) United States $0.009B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.009B 0.00
Apricus Biosciences (APRI) United States $0.007B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.005B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.003B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
Intellipharmaceutics (IPCI) Canada $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
AGEX THERAPEUTC (AGE) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00